Absence of somatic ATM missense mutations in 58 mammary carcinomas

Cancer Genetics and Cytogenetics

Volumn 145, Issue 2, 2003, Pages 179-182

  Feng, Jinong ^a   Yan, Jin ^a   Chen, Jiesheng ^a   Schlake, Gudrun ^a   Jiang, Zefei ^a   Buzin, Carolyn H ^a   Sommer, Steve S ^a   Dritschilo, Anatoly ^b  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

AFRICA; ARTICLE; BREAST CARCINOMA; CARCINOGENESIS; CYTOGENETICS; DNA SEQUENCE; GENETIC POLYMORPHISM; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MISSENSE MUTATION; NONSENSE MUTATION; PRIORITY JOURNAL; ROBOTICS; SOMATIC MUTATION; WESTERN HEMISPHERE;

EID: 0042154132     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(03)00120-1     Document Type: Article

References (28)

1. Savitsky K., Bar-Shira A., Gilad S., Rotman G., Ziv Y., Vanagaite L., Tagle D.A., Smith S., Uziel T., Sfez S., Ashkenazi M., Pecker I., Frydman M., Harnik R., Pantanjali S.R., Simmons A., Clines G.A., Sartiel A., Gatti R.A., Chessa L., Sanal O., Lavin M.F., Jaspers N.G.J., Taylor A.M.R., Arlett C.F., Miki T., Weissman S.M., Lovett M., Collins F.S., Shiloh Y. A single ataxia telangiectasia gene with a product similar to P1-3 kinase. Science. 268:1995;1749-1753.
2. Gatti R.A., Tward A., Concannon P. Cancer risk in ATM heterozygotes: a model of phenotypic and mechanistic differences between missense and truncating mutations. Mol Genet Metab. 68:1999;419-423.
3. Buzin C., Gatti R.A., Nguyen V.Q., Wen C.Y., Mitui M., Sanal O., Chen J.S., Nozari G., Mengos A., Li X., Fujimura F., Sommer S.S. Comprehensive scanning of the ATM gene with DOVAM-S. Hum Mutat. 21:2002;123-131.
4. Swift M., Morrell D., Massey R.B., Chase C.L. Incidence of cancer in 161 families affected by ataxia-telangiectasia. N Engl J Med. 325:1991;1831-1836.
5. Easton D.F. Cancer risks in A-T heterozygotes. Int J Radiat Biol. 66:1994;S177-S182.
6. Athma P., Rappaport R., Swift M. Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer. Cancer Genet Cytogenet. 92:1996;130-134.
7. Stankovic T., Kidd A.M., Sutcliffe A., McGuire G.M., Robinson P., Weber P., Bedenham T., Bradwell A.R., Easton D.F., Lennox G.G., Haites N., Byrd P.J., Taylor A.M. ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer. Am J Hum Genet. 62:1998;334-345.
8. Angele S., Hall J. The ATM gene and breast cancer: is it really a risk factor? Mutat Res. 462:2000;167-178.
9. Geoffroy-Perez B., Janin N., Ossian K., Lauge A., Croquette M.F., Griscelli C., Debre M., Bressac-de-Paillerets B., Aurias A., Stoppa-Lyonnet D., Andrieu N. Cancer risk in heterozygotes for ataxia-telangiectasia. Int J Cancer. 93:2001;288-293.
10. Janin N., Andrieu N., Ossian K., Lauge A., Croquette M.F., Griscelli C., Debre M., Bressac-de-Paillerets B., Aurias A., Stoppa-Lyonnet D. Breast cancer risk in ataxia telangiectasia (AT) heterozygotes: haplo- type study in French AT families. Br J Cancer. 80:1999;1042-1045.
11. Olsen J.H., Hahnemann J.M., Borresen-Dale A.L., Brondum-Nielsen K., Hammarstrom L., Kleinerman R., Kaariainen H., Lonnqvist T., Sankila R., Seersholm N., Tretli S., Yuen J., Boice J.D. Jr., Tucker M. Cancer in patients with ataxia-telangiectasia and in their relatives in the nordic countries. J Natl Cancer Inst. 93:2001;121-127.
12. Chen J., Birkholtz G.G., Lindblom P., Rubio C., Lindblom A. The role of ataxia-telangiectasia heterozygotes in familial breast cancer. Cancer Res. 58:1998;1376-1379.
13. FitzGerald M.G., Bean J.M., Hegde S.R., Unsal H., MacDonald D.J., Harkin D.P., Finkelstein D.M., Isselbacher K.J., Haber D.A. Heterozygous ATM mutations do not contribute to early onset of breast cancer. Nat Genet. 15:1997;307-310.
14. Sommer S.S., Buzin C.H., Jung M., Zheng J., Liu Q., Jeong S.J., Moulds J., Nguyen V.Q., Feng J., Bennett W.P., Dritschilo A. Elevated frequency of ATM gene missense mutations in breast cancer relative to ethnically matched controls. Cancer Genet Cytogenet. 134:2002;25-32.
15. Dork T., Bendix R., Bremer M., Rades D., Klopper K., Nicke M., Skawran B., Hector A., Yamini P., Steinmann D., Weise S., Stuhrmann M., Karstens J.H. Spectrum of ATM gene mutations in a hospital-based series of unselected breast cancer patients. Cancer Res. 61:2001;7608-7615.
16. Teraoka S.N., Malone K.E., Doody D.R., Suter N.M., Ostrander E.A., Daling J.R., Concannon P. Increased frequency of ATM mutations in breast carcinoma patients with early onset disease and positive family history. Cancer. 92:2001;479-487.
17. Chenevix-Trench G., Spurdle A.B., Gatei M., Kelly H., Marsh A., Chen X., Donn K., Cummings M., Nyholt D., Jenkins M.A., Scott C., Pupo G.M., Dork T., Bendix R., Kirk J., Tucker K., McCredie M.R., Hopper J.L., Sambrook J., Mann G.J., Khanna K.K. Dominant negative ATM mutations in breast cancer families. J Natl Cancer Inst. 94:2002;205-215.
18. Koike M., Takeuchi S., Park S., Hatta Y., Yokota J., Tsuruoka N., Koeffler H.P. Ovarian cancer: loss of heterozygosity frequently occurs in the ATM gene, but structural alterations do not occur in this gene. Oncology. 56:1999;160-163.
19. Vorechovsky I., Luo L., Dyer M.J., Catovsky D., Amlot P.L., Yaxley J.C., Foroni L., Hammarstrom L., Webster A.D., Yuille M.A. Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia. Nat Genet. 17:1997;96-99.
20. Schaffner C., Idler I., Stilgenbauer S., Dohner H., Lichter P. Mantle cell lymphoma is characterized by inactivation of the ATM gene. Proc Natl Acad Sci USA. 97:2000;2773-2778.
21. Laake K., Odegard A., Andersen T.I., Bukholm I.K., Karesen R., Nesland J.M., Ottestad L., Shiloh Y., Borresen-Dale A.L. Loss of heterozygosity at 11q23.1 in breast carcinomas: indication for involvement of a gene distal and close to ATM. Genes Chromosomes Cancer. 18:1997;175-180.
22. Vorechovsky I., Rasio D., Luo L., Monaco C., Hammarstrom L., Webster A.D., Zaloudik J., Barbanti-Brodani G., James M., Russo G. The ATM gene and susceptibility to breast cancer: analysis of 38 breast tumors reveals no evidence for mutation. Cancer Res. 56:1996;2726-2732.
23. Gustafson S., Proper J.A., Bowie E.J.W., Sommer S.S. Parameters affecting the yield of DNA from human blood. Anal Biochem. 165:1987;294-299.
24. Buzin C.H., Wen C.Y., Nguyen V.Q., Nozari G., Mengos A., Li X., Chen J.S., Liu Q., Gatti R.A., Fujimura F.K., Sommer S.S. Scanning by DOVAM-S detects all unique sequence changes in blinded analyses: evidence that the scanning conditions are generic. Biotechniques. 28:2000;746-753.
25. Liu Q., Feng J., Buzin C., Wen C., Nozari G., Mengos A., Nguyen V., Liu J., Crawford F., Fujimura F.K., Sommer S.S. Detection of virtually all mutations-SSCP (DOVAM-S): a rapid method for mutation scanning with virtually 100% sensitivity. Biotechniques. 26:1999;932-942.
26. Thorstenson Y.R., Shen P., Tusher V.G., Wayne T.L., Davis R.W., Chu G., Oefner P.J. Global analysis of ATM polymorphism reveals significant functional constraint. Am J Hum Genet. 69:2001;396-412.
27. Sommer S.S., Jiang Z., Feng J., Buzin C., Zheng J., Jung M., Dritschilo A. ATM missense mutations are frequent in patients with breast cancer. Cancer Genet Cytogenet. 145:2003;115-120.
28. Osorio A., De La Hoya M., Rodriguez-Lopez R., Martinez-Ramirez A., Cazorla A., Granizo J.J., Esteller M., Rivas C., Caldes T., Benitez J. Loss of heterozygosity analysis at the BRCA loci in tumor samples from patients with familial breast cancer. Int J Cancer. 99:2002;305-309.